Skip to main content

Table 1 Classification of sAMC patients according to current recommendations

From: Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis

  sAMC
n = 46
Clinical Presentation
 Acute Chest Pain 26 (57%)
 New-onset or worsening of dyspnoea at rest or exercise: 34 (74%)
  NYHA I 12 (26%)
  NYHA II 14 (30%)
  NYHA III 14 (30%)
  NYHA IV 6 (13%)
 Arrhythmia symptoms; Palpitations; Syncope 9 (20%)
 Fatigue 33 (72%)
Diagnostic Criteria  
 Current Infection 36 (78%)
 Hs-Troponin (ng/ml) 375 ± 512
 Hs-Troponin >14 ng/ml 38 (83%)
 Suspicious ECG (%) 32 (70%)
 Functional and structural abnormalities on cardiac imaging (CMR/Echo) 46 (100%)
  1. Abbreviations: sAMC suspected acute myocarditis, ECG Electrocardiogram, Echo Echocardiography, NYHA New York Heart Association, CMR Cardiovascular Magnetic Resonance
  2. Values represent mean ± standard deviation or percentage